Insider · CIK 0002076177
Robert Charles Jahr
Files at OTLK (Outlook Therapeutics, Inc.). First filing -, latest -.
In brief
Robert Charles Jahr files SEC Form 4 as CEO and director at OTLK (Outlook Therapeutics, Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Robert Charles Jahr has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 4 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 14, 2026 | OTLK Outlook Therapeutics, Inc. | POpen-market purchase Common Stock | +151,515 | - | - | 151,515 | Aug 14, 2026 |
| Aug 14, 2026 | OTLK Outlook Therapeutics, Inc. | POpen-market purchase Warrants (right to buy)derivative | +151,515 | - | - | 151,515 | Aug 14, 2026 |
| Jul 21, 2026 | OTLK Outlook Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +100,000 | $0.00 | $0 | 100,000 | Jul 23, 2026 |
| Jul 1, 2025 | OTLK Outlook Therapeutics, Inc. | AGrant or award Stock Option (Right to Buy)derivative | +800,000 | $0.00 | $0 | 800,000 | Jul 9, 2025 |
Questions about Robert Charles Jahr
Answered from the filings on this page, as of the latest one.
Is Robert Charles Jahr buying or selling?
Robert Charles Jahr has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Robert Charles Jahr's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Robert Charles Jahr has 0.
Where does Robert Charles Jahr file Form 4?
Robert Charles Jahr has filed Form 4 at OTLK (Outlook Therapeutics, Inc.) as Chief Executive Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.